Science Explorer Back to mapMap
Discussion
Hospital / health system · Louisville · United States

Advanced Cancer Therapeutics

advancedcancertherapeutics.comROR OpenAlex
Research works
116
▼ 5% vs 2018-21
Citations
4.4k
38.0 per fractional work
Top-10% rate
7.1%
all institutions 10.0%
Open access
33%
world 40%
International
23%
world 18%
Advanced Cancer Therapeutics

Not ranked overall: Advanced Cancer Therapeutics is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Advanced Cancer Therapeutics work in?

In all years, 63% of research at Advanced Cancer Therapeutics is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (59%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (3%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 73 fractional works · 62.5% of its workMedicine: 69 fractional works · 59.3% of its workOncology: 15 fractional works · 12.7% of its workPulmonary and Respiratory Medicine: 10 fractional works · 9.0% of its workSurgery: 6 fractional works · 4.9% of its workGenetics: 5 fractional works · 4.3% of its workHematology: 5 fractional works · 4.2% of its workPathology and Forensic Medicine: 4 fractional works · 3.1% of its workNeurology: 4 fractional works · 3.0% of its workEpidemiology: 2 fractional works · 2.0% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 2.0% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 1.6% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.3% of its workPhysiology: 1 fractional works · 1.2% of its workRheumatology: 1 fractional works · 0.9% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.9% of its workPharmacology: 1 fractional works · 0.8% of its workOtorhinolaryngology: 1 fractional works · 0.8% of its workObstetrics and Gynecology: 1 fractional works · 0.7% of its workReproductive Medicine: 1 fractional works · 0.6% of its workOrthopedics and Sports Medicine: 1 fractional works · 0.5% of its workDermatology: 1 fractional works · 0.5% of its workInfectious Diseases: 1 fractional works · 0.5% of its workImmunology and Allergy: 1 fractional works · 0.5% of its workAnesthesiology and Pain Medicine: 1 fractional works · 0.5% of its workHepatology: 1 fractional works · 0.5% of its workOphthalmology: 0 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workInternal Medicine: 0 fractional works · 0.2% of its workNephrology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workHealth Professions: 2 fractional works · 1.8% of its workHealth Information Management: 1 fractional works · 0.9% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workMedical Terminology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workNursing: 2 fractional works · 1.4% of its workIssues, ethics and legal aspects: 1 fractional works · 0.9% of its workNutrition and Dietetics: 1 fractional works · 0.5% of its workDentistry: 0 fractional works · 0.1% of its workLife Sciences: 30 fractional works · 26.2% of its workBiochemistry, Genetics and Molecular Biology: 25 fractional works · 21.5% of its workMolecular Biology: 14 fractional works · 12.0% of its workCancer Research: 5 fractional works · 4.0% of its workGenetics: 4 fractional works · 3.6% of its workCell Biology: 1 fractional works · 1.0% of its workPhysiology: 0 fractional works · 0.3% of its workBiotechnology: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.4% of its workImmunology and Microbiology: 4 fractional works · 3.4% of its workImmunology: 4 fractional works · 3.0% of its workVirology: 0 fractional works · 0.4% of its workNeuroscience: 1 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workSocial Sciences: 9 fractional works · 7.7% of its workSocial Sciences: 3 fractional works · 2.4% of its workSociology and Political Science: 2 fractional works · 1.6% of its workPolitical Science and International Relations: 1 fractional works · 0.6% of its workTransportation: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 3 fractional works · 2.4% of its workAccounting: 1 fractional works · 0.6% of its workManagement of Technology and Innovation: 1 fractional works · 0.6% of its workOrganizational Behavior and Human Resource Management: 1 fractional works · 0.6% of its workManagement Information Systems: 0 fractional works · 0.3% of its workStrategy and Management: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 2 fractional works · 1.5% of its workEconomics and Econometrics: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workArts and Humanities: 1 fractional works · 1.1% of its workMusic: 1 fractional works · 0.9% of its workHistory and Philosophy of Science: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.3% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.3% of its workPhysical Sciences: 4 fractional works · 3.6% of its workEngineering: 2 fractional works · 1.4% of its workBiomedical Engineering: 2 fractional works · 1.4% of its workChemistry: 1 fractional works · 0.7% of its workOrganic Chemistry: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workMaterials Science: 1 fractional works · 0.6% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.3% of its workStatistics and Probability: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 0.1% of its workALL ITS WORKAdvanced CancerTherapeutics116fractional works, all years
Life Sciences26%Physical Sciences4%Health Sciences63%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine6959.3%
    2. Health Professions21.8%
    3. Nursing21.4%
    4. Dentistry00.1%
    1. Biochemistry, Genetics and Molecular Biology2521.5%
    2. Immunology and Microbiology43.4%
    3. Neuroscience10.8%
    4. Agricultural and Biological Sciences00.4%
    5. Pharmacology, Toxicology and Pharmaceutics00.1%
    1. Social Sciences32.4%
    2. Business, Management and Accounting32.4%
    3. Economics, Econometrics and Finance21.5%
    4. Arts and Humanities11.1%
    5. Decision Sciences00.3%
    1. Engineering21.4%
    2. Chemistry10.7%
    3. Materials Science10.6%
    4. Mathematics00.3%
    5. Physics and Astronomy00.2%
    6. Environmental Science00.2%
    7. Computer Science00.2%
    8. Chemical Engineering00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.38× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.68× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 7.26× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 2.55× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.72× its world share, 0 worksChemistryEngineering: 0.30× its world share, 0 worksEngineeringMaterials Science: 0.72× its world share, 0 worksMaterials ScienceMedicine: 1.11× its world share, 2 worksMedicineBusiness, Management and Accounting: 3.83× its world share, 1 worksBusiness, Management…Economics, Econometrics and Finance: 4.20× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.71× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.3×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Immunology and Microbiology7.26×0 works
  2. Biochemistry, Genetics and Molecular Biology5.68×2 works
  3. Economics, Econometrics and Finance4.20×1 works
  4. Business, Management and Accounting3.83×1 works
  5. Pharmacology, Toxicology and Pharmaceutics2.55×0 works
  6. Medicine1.11×2 works
  7. Chemistry0.72×0 works
  8. Materials Science0.72×0 works
  9. Social Sciences0.71×1 works
  10. Agricultural and Biological Sciences0.38×0 works
  11. Engineering0.30×0 works

What are the most cited papers from Advanced Cancer Therapeutics?

The most cited paper from Advanced Cancer Therapeutics is "Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer" (Navneet Kaur Dhillon, Bharat Bhushan Aggarwal, Robert Alan Newman et al., 2008), with 1,333 citations. Next come "Autophagy as a target for anticancer therapy" (816) and "Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells" (511).

Most cited papers
#PaperReleasedCitations
1 Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer Navneet Kaur Dhillon, Bharat Bhushan Aggarwal, Robert Alan Newman et al. · Clinical Cancer Research 15 Jul 2008 1,333
2 Autophagy as a target for anticancer therapy Filip Jankú, David James McConkey, David S. Hong et al. · Nature Reviews Clinical Oncology Review 17 May 2011 816
3 Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells Kip A. West, John Brognard, Amy Sanders Clark et al. · Journal of Clinical Investigation Open access 2003 511
4 Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells Michael G. Sun, Zeev E. Estrov, Yuan Ji et al. · Molecular Cancer Therapeutics Open access Mar 2008 412
5 Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results Alex Y. C. Chang, K. Kim, John H. Glick et al. · JNCI Journal of the National Cancer Institute 3 Mar 1993 339
All 59 most cited papers, with filters and sorting

Which keywords describe research at Advanced Cancer Therapeutics?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Prognostic Factors, Targeted Therapy, Immunotherapy, Clinical Trials, Cancer Therapy, Genomic Profiling and ALK Inhibitors.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy14▲ 17×17 topics
  2. Prognostic Factors9▲ 17×10 topics
  3. Targeted Therapy8▲ 33×5 topics
  4. Immunotherapy8▲ 10×14 topics
  5. Clinical Trials7▲ 9.6×9 topics
  6. Cancer Therapy7▲ 9.0×13 topics
  7. Cancer6▲ 3.6×28 topics
  8. Genomic Profiling5▲ 44×2 topics
  9. ALK Inhibitors5▲ 76×1 topic
  10. EGFR Mutations5▲ 76×1 topic
  11. Tumor Microenvironment5▲ 12×7 topics
  12. Rituximab5▲ 25×2 topics
  13. Prognosis4▲ 11×6 topics
  14. Genetic Mutations4▲ 6.6×7 topics
  15. Cetuximab4▲ 39×2 topics
  16. Breast Cancer4▲ 11×6 topics
  17. Clinical Practice Guidelines4▲ 5.5×7 topics
  18. Precision Medicine4▲ 10.0×4 topics
  19. Survival Analysis4▲ 11×6 topics
  20. Radiotherapy4▲ 8.0×7 topics
  21. Hematopoietic Stem Cells3▲ 29×3 topics
  22. Therapeutic Targets3▲ 12×4 topics
  23. PET Imaging3▲ 13×4 topics
  24. Regulation3▲ 4.6×7 topics
  25. Apoptosis3▲ 6.9×5 topics
  26. Mutation3▲ 18×2 topics
  27. Molecular Characterization3▲ 14×5 topics
  28. Tumor Suppression3▲ 23×3 topics
  29. BRAF Mutation3▲ 36×2 topics
  30. Molecular Subtypes3▲ 29×2 topics
  31. Chronic Lymphocytic Leukemia3▲ 52×1 topic
  32. Genomic Aberrations3▲ 52×1 topic
  33. Fluorouracil3▲ 73×1 topic
  34. KRAS Mutations3▲ 73×1 topic
  35. Nuclear Receptors3▲ 13×4 topics
  36. Lymphoma2▲ 15×3 topics
  37. Transcriptional Regulation2▲ 8.4×5 topics
  38. Cell Cycle2▲ 36×1 topic
  39. p532▲ 47×1 topic
  40. Signaling2▲ 17×4 topics

Which research topics does Advanced Cancer Therapeutics publish most on?

By volume in 2022-now: Sustainability and Innovation in Business, Land Use and Management, Economic and Business Development Strategies and Accounting and Financial Management.

Sustainability and Innovation in Business: 1 fractional worksLand Use and Management1Land Use and Management: 1 fractional worksEconomic and Business Development Strategies: 1 fractional worksAccounting and Financial…0Accounting and Financial Management: 0 fractional worksHIV Research and Treatment0HIV Research and Treatment: 0 fractional worksSingle-cell and spatial …0Single-cell and spatial transcriptomics: 0 fractional worksPluripotent Stem Cells Research: 0 fractional works3D Printing in Biomedical Research: 0 fractional worksHistone Deacetylase Inhibitors Research: 0 fractional worksUrinary and Genital Oncology Studies: 0 fractional works
Management of Technology and InnovationPolitical Science and International RelationsEconomics and EconometricsAccounting4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Sustainability and Innovation in Business Management of Technology and Innovation 1 works
  2. 2 Land Use and Management Political Science and International Relations 1 works
  3. 3 Economic and Business Development Strategies Economics and Econometrics 1 works
  4. 4 Accounting and Financial Management Accounting 0 works
  5. 5 HIV Research and Treatment Virology 0 works
  6. 6 Single-cell and spatial transcriptomics Molecular Biology 0 works
  7. 7 Pluripotent Stem Cells Research Molecular Biology 0 works
  8. 8 3D Printing in Biomedical Research Biomedical Engineering 0 works
  9. 9 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
  10. 10 Urinary and Genital Oncology Studies Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.1%not open66.9%

World: 40% of research is openly available.

with international co-authors22.9%domestic only77.1%

World: 18% is written across borders.

How has Advanced Cancer Therapeutics's research output changed?

Output in 2022-2025 was 5% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Advanced Cancer Therapeutics as a percentage of every work published that year, 0.0000031% in 2024.

still counting0.00020%0.00040%0.00060%Advanced Cancer Therapeutics0.000055% in 202519801990200020102020

Fractional works of Advanced Cancer Therapeutics over all fractional works that year. How the balance of science has shifted.

Other research institutions in Louisville

All research institutions in Louisville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Advanced Cancer Therapeutics. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.